BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 8103818)

  • 1. Apolipoprotein E and Alzheimer's disease.
    Scott J
    Lancet; 1993 Sep; 342(8873):696. PubMed ID: 8103818
    [No Abstract]   [Full Text] [Related]  

  • 2. Apolipoprotein E, A beta-amyloid, and the molecular pathology of Alzheimer's disease. Therapeutic implications.
    Kaplitt M; Gouras GK; Makimura H; Jovanovic J; Sweeney D; Greengard P; Relkin NR; Gandy S
    Ann N Y Acad Sci; 1996 Dec; 802():42-9. PubMed ID: 8993483
    [No Abstract]   [Full Text] [Related]  

  • 3. Apolipoprotein E and Alzheimer's disease.
    Stephens D
    J R Soc Health; 1996 Feb; 116(1):41-3. PubMed ID: 8683540
    [No Abstract]   [Full Text] [Related]  

  • 4. Apolipoprotein E4 and Alzheimer's disease pathology in Lewy body disease and in other beta-amyloid-forming diseases.
    Pickering-Brown SM; Mann DM; Bourke JP; Roberts DA; Balderson D; Burns A; Byrne J; Owen F
    Lancet; 1994 May; 343(8906):1155. PubMed ID: 7818636
    [No Abstract]   [Full Text] [Related]  

  • 5. New piece in Alzheimer's puzzle.
    Travis J
    Science; 1993 Aug; 261(5123):828-9. PubMed ID: 8346434
    [No Abstract]   [Full Text] [Related]  

  • 6. Apolipoprotein E and Alzheimer's disease: the protective effects of ApoE2 and E3.
    Rebeck GW; Kindy M; LaDu MJ
    J Alzheimers Dis; 2002 Jun; 4(3):145-54. PubMed ID: 12226533
    [No Abstract]   [Full Text] [Related]  

  • 7. ApoE4: is it the absence of good or the presence of bad?
    Ashford JW
    J Alzheimers Dis; 2002 Jun; 4(3):141-3. PubMed ID: 12226532
    [No Abstract]   [Full Text] [Related]  

  • 8. Biological transgenic mouse models of Alzheimer's disease.
    Crews L; Rockenstein E; Masliah E
    Handb Clin Neurol; 2008; 89():291-301. PubMed ID: 18631753
    [No Abstract]   [Full Text] [Related]  

  • 9. ApoE, amyloid, and Alzheimer's disease.
    Hardy J
    Science; 1994 Jan; 263(5146):454-5. PubMed ID: 8290946
    [No Abstract]   [Full Text] [Related]  

  • 10. APOE in Alzheimer's disease and neurodegeneration.
    Butterfield DA; Johnson LA
    Neurobiol Dis; 2020 Jun; 139():104847. PubMed ID: 32209402
    [No Abstract]   [Full Text] [Related]  

  • 11. Apolipoprotein E polymorphism and Alzheimer's disease.
    Poirier J; Davignon J; Bouthillier D; Kogan S; Bertrand P; Gauthier S
    Lancet; 1993 Sep; 342(8873):697-9. PubMed ID: 8103819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein E-epsilon 2 and Alzheimer's disease: genotype influences pathologic phenotype.
    Lippa CF; Smith TW; Saunders AM; Hulette C; Pulaski-Salo D; Roses AD
    Neurology; 1997 Feb; 48(2):515-9. PubMed ID: 9040748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.
    Davidson Y; Gibbons L; Pritchard A; Hardicre J; Wren J; Tian J; Shi J; Stopford C; Julien C; Thompson J; Payton A; Thaker U; Hayes AJ; Iwatsubo T; Pickering-Brown SM; Pendleton N; Horan MA; Burns A; Purandare N; Lendon CL; Neary D; Snowden JS; Mann DM
    J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):515-7. PubMed ID: 16543533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease.
    Schmechel DE; Saunders AM; Strittmatter WJ; Crain BJ; Hulette CM; Joo SH; Pericak-Vance MA; Goldgaber D; Roses AD
    Proc Natl Acad Sci U S A; 1993 Oct; 90(20):9649-53. PubMed ID: 8415756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cholesterol and Alzheimer's disease].
    Kálmán J; Janka Z
    Orv Hetil; 2005 Sep; 146(37):1903-11. PubMed ID: 16255374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A quartet of Down's syndrome, Alzheimer's disease, cerebral amyloid angiopathy, and cerebral haemorrhage: interacting genetic risk factors.
    McCarron MO; Nicoll JA; Graham DI
    J Neurol Neurosurg Psychiatry; 1998 Sep; 65(3):405-6. PubMed ID: 9728967
    [No Abstract]   [Full Text] [Related]  

  • 17. Alzheimer's Disease-Current Status and Future Directions.
    Bhardwaj D; Mitra C; Narasimhulu CA; Riad A; Doomra M; Parthasarathy S
    J Med Food; 2017 Dec; 20(12):1141-1151. PubMed ID: 29131706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.
    Strittmatter WJ; Saunders AM; Schmechel D; Pericak-Vance M; Enghild J; Salvesen GS; Roses AD
    Proc Natl Acad Sci U S A; 1993 Mar; 90(5):1977-81. PubMed ID: 8446617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein E and Alzheimer disease.
    Strittmatter WJ; Roses AD
    Proc Natl Acad Sci U S A; 1995 May; 92(11):4725-7. PubMed ID: 7761390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetics of Alzheimer's disease: an insight into presenilins and apolipoprotein E instigated neurodegeneration.
    Obulesu M; Somashekhar R; Venu R
    Int J Neurosci; 2011 May; 121(5):229-36. PubMed ID: 21545304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.